Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Jul
31
2023
UCB, Inc. v. Actavis Laboratories UT, Inc. No. 2021-1924, (Fed. Cir. Apr. 12, 2023) Sheppard, Mullin, Richter & Hampton LLP
Jul
31
2023
Proposed Class Action Dismissed Over Lack of Standing Keller and Heckman LLP
Jul
31
2023
The 2024 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know ArentFox Schiff LLP
Jul
31
2023
Bipartisan Group of Representatives Calls on EPA to Assess the Risks of PFAS in Fluorinated Containers Bergeson & Campbell, P.C.
Jul
31
2023
APHIS 2022 Impact Report Includes Summary of Biotechnology Activities Bergeson & Campbell, P.C.
Jul
28
2023
Will Mississippi’s List of Qualifying Conditions for Medical Cannabis Soon Be Expanded? Bradley Arant Boult Cummings LLP
Jul
28
2023
Amendment to House Bill Threatens Funding of Organic Standards Keller and Heckman LLP
Jul
27
2023
CMS Proposes Changes to Medicare Provider Enrollment Rules Polsinelli PC
Jul
27
2023
New Medicare Marketing Definition Squire Patton Boggs (US) LLP
Jul
27
2023
CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022 Foley & Lardner LLP
Jul
27
2023
FDA Maintains Focus on “Intended Use” for Software-Enabled Medical Devices Sheppard, Mullin, Richter & Hampton LLP
Jul
27
2023
FDA Denies Request to Reconsider Petition on Phthalates in Food Packaging Keller and Heckman LLP
Jul
26
2023
Bipartisan Legislation Would Strengthen USDA’s BioPreferred Program Bergeson & Campbell, P.C.
Jul
26
2023
July 2023 EU’s New HBER and Horizontal Guidelines: Main Changes Greenberg Traurig, LLP
Jul
25
2023
First Nonprescription Birth Control Pill Approved for Marketing by FDA: A Milestone for Reproductive Health Mintz
Jul
25
2023
The Netherlands Provides Taste Testing of Cell-Cultivated Meat and Seafood Keller and Heckman LLP
Jul
25
2023
Real Estate Beneficial Ownership Regulatory Alert: Complying with Foreign Ownership Reporting Requirements in US Real Estate K&L Gates
Jul
25
2023
Big Tobacco Bets Big On Cannabis Bradley Arant Boult Cummings LLP
Jul
25
2023
Washington State’s Aggressive Approach to Preventing Intoxicating Hemp Cannabinoids May Be Adopted in Other States Wilson Elser Moskowitz Edelman & Dicker LLP
Jul
24
2023
Regulators Send Warning Letter to Hospitals and Telehealth Providers About Tracking Technology Use Sheppard, Mullin, Richter & Hampton LLP
Jul
21
2023
EPA Extends Comment Period on Proposed SNURs for 18 Chemicals Made from Plastic Waste-Based Feedstocks Bergeson & Campbell, P.C.
Jul
21
2023
Reintroduced Bill Seeks Legal Pathway for CBD in Food Keller and Heckman LLP
Jul
21
2023
Post-Dobbs Hospital Risk Assessment, Part 2: Impacts Beyond Abortion ArentFox Schiff LLP
Jul
20
2023
Changing Landscape: Federal and State Regulators Focus on Protecting Consumer Health Data Foley & Lardner LLP
Jul
20
2023
U.S. Executive Branch Update – July 20, 2023 Squire Patton Boggs (US) LLP
Jul
20
2023
Lab Study Shows Oral Antacid Drug Performs Differently When Mixed with Various Food Vehicles Keller and Heckman LLP
Jul
19
2023
EPA Announces Release of Guidance for the Evaluation of Products for Claims against Viruses Bergeson & Campbell, P.C.
Jul
19
2023
USDA FSIS Implements Directives to Inspection Program Personnel as Cell-Cultured Meats Begin to Enter the U.S. Market. Keller and Heckman LLP
Jul
19
2023
Trending in Telehealth: June 27 – July 10, 2023 McDermott Will & Emery
Jul
19
2023
IP Toolbox Is Crucial In AI-Powered Drug Discovery Foley & Lardner LLP
Jul
18
2023
Complex Healthcare Litigation Toolkit: The Use of Plaintiff Fact Sheets and Summary Jury Trials Foley & Lardner LLP
Jul
18
2023
U.S. Executive Branch Update – July 18, 2023 Squire Patton Boggs (US) LLP
Jul
18
2023
EPA Extends Comment Period on Proposed Updates to TSCA New Chemicals Regulations; Comments Due August 8, 2023 Bergeson & Campbell, P.C.
Jul
18
2023
Hospital Price Transparency Changes in the Calendar Year 2024 Hospital Outpatient Prospective Payment System Proposed Rule Nelson Mullins
Jul
18
2023
District of Columbia Employers Take Notice: City’s Cannabis Employment Protections Amendments Act Takes Effect ArentFox Schiff LLP
Jul
18
2023
Report: Digital Health in India in 2023 Nishith Desai Associates
Jul
18
2023
This Week in 340B: July 6 – 17, 2023 McDermott Will & Emery
Jul
18
2023
Those Aren’t Doritos: FTC and FDA Send Warning Letters to Companies Marketing Delta-8 Infused Munchies Mintz
Jul
18
2023
Montana Enacts Genetic Information Privacy Law Jackson Lewis P.C.
Jul
17
2023
California Assembly Passes Bill that Would Prohibit Certain Food Additives Greenberg Traurig, LLP
Jul
17
2023
In a Landmark Decision, China’s Supreme Court Reverses Lower Court Decision Banning Excessively High Prices on a Patent-Protected Pharmaceutical Product Greenberg Traurig, LLP
Jul
17
2023
Healthcare Preview for The Week Of: July 17, 2023 McDermott Will & Emery
Jul
17
2023
Petition Filed to Add Methyl Ethyl Ketoxime to List of Chemical Substances Subject to Superfund Excise Tax Bergeson & Campbell, P.C.
Jul
17
2023
SEC Cannabis Enforcement Continuing to Grow this Past Spring Foley & Lardner LLP
Jul
17
2023
FDA Extends Enforcement Discretion Policies in FSMA Guidances Involving Onsite Visits Abroad Due to the Ongoing, International Impact of COVID-19 Keller and Heckman LLP
Jul
17
2023
Key Takeaways from the FDA’s First Draft Guidance on Clinical Trials with Psychedelic Drugs Foley & Lardner LLP
Jul
14
2023
Navigating the Pricing Regulation for Pharmaceuticals and Medical Devices in India – Part B [Podcast] Nishith Desai Associates
Jul
14
2023
Navigating the Pricing Regulation for Pharmaceuticals and Medical Devices in India – Part A Nishith Desai Associates
Jul
14
2023
FDA Releases Final Guidance on Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements Sheppard, Mullin, Richter & Hampton LLP
Jul
14
2023
CMS Releases Proposed Remedy for 340 B-Acquired Drugs Purchased in Cys 2018–2022 McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins